CK
Chander Kant Vats
About Chander Kant Vats
Data last updated:
Chander Kant Vats is a Director at Advench Pharmaceutical Private Limited (since 2023) and Director at Cellcore Biotech Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.8 Lakh; the largest is Advench Pharmaceutical Private Limited at ₹4.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Advench Pharmaceutical Private Limited U47721DL2023PTC412388 | Director | 12 Apr 2023 | 2023 | ₹4.6 Lakh (FY 2025) | Active |
| Cellcore Biotech Private Limited U47721DL2023PTC422844 | Director | 20 Nov 2023 | 2023 | ₹1.2 Lakh (FY 2025) | Active |
Board colleagues of Chander Kant Vats
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vaishali Vats | 10397369 | Advench Pharmaceutical Private Limited , Cellcore Biotech Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chander Kant Vats
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chander Kant Vats
Chander Kant Vats currently holds 2 directorships: Advench Pharmaceutical Private Limited (Director, since 12 Apr 2023, revenue ₹4.6 Lakh (FY 2025)); Cellcore Biotech Private Limited (Director, since 20 Nov 2023, revenue ₹1.2 Lakh (FY 2025)).
Chander Kant Vats was first appointed on 12 Apr 2023 as Director at Advench Pharmaceutical Private Limited.
The 2 current companies of Chander Kant Vats that report revenue have a combined latest revenue of ₹5.8 Lakh: Advench Pharmaceutical Private Limited ₹4.6 Lakh (FY 2025); Cellcore Biotech Private Limited ₹1.2 Lakh (FY 2025).
The current boards of Chander Kant Vats's companies include Vaishali Vats (Advench Pharmaceutical Private Limited).